carbachol has been researched along with Experimental Lung Inflammation in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cadieux, A | 1 |
Monast, NP | 1 |
Pomerleau, F | 1 |
Fournier, A | 1 |
Lanoue, C | 1 |
Nemmar, A | 1 |
Delaunois, A | 1 |
Nemery, B | 1 |
Dessy-Doizé, C | 1 |
Beckers, JF | 1 |
Sulon, J | 1 |
Gustin, P | 1 |
2 other studies available for carbachol and Experimental Lung Inflammation
Article | Year |
---|---|
Bronchoprotector properties of calcitonin gene-related peptide in guinea pig and human airways. Effect of pulmonary inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Bronchi; Bronchoconstriction; Calcitonin Gene-R | 1999 |
Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells.
Topics: Animals; Capsaicin; Carbachol; Chemotaxis, Leukocyte; Female; Histamine; Histamine Antagonists; Intu | 1999 |